Kimberly J Genske, in Amherst, WI - Social Worker

Kimberly J Genske, is a Social Worker - Clinical based in Amherst, Wisconsin. Kimberly J Genske is licensed to practice in * (Not Available) (license number ) and her current practice location is 10734 Otto Rd, Amherst, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (715) 252-3376.

NPI number for Kimberly J Genske is 1275881203 and her current mailing address is 10734 Otto Rd, Amherst, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1275881203.

Contact Information

	Kimberly J Genske,
	10734 Otto Rd, Amherst, WI 54406-9330
	(715) 252-3376
	Not Available

Healthcare Provider's Profile

Full Name	Kimberly J Genske
Gender	Female
Speciality	Social Worker - Clinical
Location	10734 Otto Rd, Amherst, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1275881203
Provider Enumeration Date: 08/23/2012
Last Update Date: 08/23/2012

Medical Identifiers

Medical identifiers for Kimberly J Genske such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275881203	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kimberly J Genske is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kimberly J Genske, 10734 Otto Rd, Amherst, WI 54406-9330 Ph: (715) 252-3376	Kimberly J Genske, 10734 Otto Rd, Amherst, WI 54406-9330 Ph: (715) 252-3376

News Archive

High-throughput ChIP analysis platform introduced in new technical article

Porvair Sciences, in conjunction with researchers at Swansea University (UK) have written a new technical article entitled 'Chromatrap® 96: a new solid-state platform for high-throughput Chromatin Immunoprecipitation (ChIP)'.

Researchers find high return-to-play rates in collegiate athletes after shoulder instability surgery

Getting back into the game is important for any athlete after a significant injury but shoulder injuries can be tricky, especially for football players.

UCI agrees to use MAggPI's web-based digital whole slide imaging to teach medical students

The University of California, Irvine School of Medicine has agreed to use web-based digital whole slide imaging developed by MAggPI in the teaching of medical students. In this collaboration, diagnostic-quality, expert-curated digital images of normal and diseased tissue will be incorporated in the teaching of histology and pathology to medical students at UCI.

Ardea Biosciences announces positive results from a phase 1 study of lead candidate for hyperuricemia and gout

Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).

PhotoMedex fourth quarter revenues increase 26% to $28.8M

PhotoMedex, Inc. today reported financial results for the three and 12 months ended December 31, 2011.

Kimberly J Genske, - Clinical Social Worker in Amherst, WI